Hikma and Amarin's generic drug case heads to Supreme Court arguments
When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching. The case could have broad implications on how new generics get ...
Credit: Viktoria Nikolova for Endpoints News April 28, 2026 01:14 PM EDTUpdated 02:33 PM PharmaLaw The Supreme Court will determine how a fish oil pill shakes up the generics market Nicole DeFeudis Senior Reporter When the Supreme Court hears arguments this week over a prescription-strength pill derived from fish oil, the entire generic drug industry will be watching. The … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that